MedTrace Logo

GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies

NCT03700047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2022-08-26

Study results available
· View outcomes & findings →

Summary

An interventional study to evaluate the safety and effectiveness of GAL1704 for cheek augmentation and the correction of midface volume deficiencies by demonstrating non-inferiority in change from baseline, relative to an active comparator.

Conditions

  • Cheek Augmentation

Interventions

DEVICE

GAL1704

new dermal filler

DEVICE

Juvederm Voluma

hyaluronic acid

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-18
Primary Completion
2019-06-10
Completion
2020-05-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03700047 on ClinicalTrials.gov